2023 Q2 Form 10-Q Financial Statement
#000181864423000006 Filed on May 11, 2023
Income Statement
Concept | 2023 Q2 | 2023 Q1 |
---|---|---|
Revenue | $571.0K | $636.0K |
YoY Change | -19.12% | -41.22% |
Cost Of Revenue | $1.911M | $2.261M |
YoY Change | 33.92% | 52.56% |
Gross Profit | -$1.340M | -$1.625M |
YoY Change | 85.85% | 306.25% |
Gross Profit Margin | -234.68% | -255.5% |
Selling, General & Admin | $8.949M | $14.82M |
YoY Change | -40.93% | -7.05% |
% of Gross Profit | ||
Research & Development | $5.897M | $9.442M |
YoY Change | -45.21% | 10.1% |
% of Gross Profit | ||
Depreciation & Amortization | $336.0K | $330.0K |
YoY Change | 31.76% | 58.65% |
% of Gross Profit | ||
Operating Expenses | $14.85M | $24.26M |
YoY Change | -42.71% | -1.05% |
Operating Profit | -$16.19M | -$25.89M |
YoY Change | -39.23% | 3.88% |
Interest Expense | $185.0K | -$533.0K |
YoY Change | -62.32% | -235.97% |
% of Operating Profit | ||
Other Income/Expense, Net | $174.0K | -$357.0K |
YoY Change | -5.43% | -828.57% |
Pretax Income | -$16.01M | -$26.25M |
YoY Change | -39.46% | 5.52% |
Income Tax | $19.00K | $19.00K |
% Of Pretax Income | ||
Net Earnings | -$16.03M | -$26.27M |
YoY Change | -39.43% | 5.56% |
Net Earnings / Revenue | -2807.53% | -4129.72% |
Basic Earnings Per Share | -$0.09 | -$0.16 |
Diluted Earnings Per Share | -$0.09 | -$0.16 |
COMMON SHARES | ||
Basic Shares Outstanding | 176.9M shares | 168.8M shares |
Diluted Shares Outstanding | 175.7M shares | 165.9M shares |
Balance Sheet
Concept | 2023 Q2 | 2023 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $58.65M | $74.09M |
YoY Change | -53.36% | -48.49% |
Cash & Equivalents | $18.39M | $20.50M |
Short-Term Investments | $40.26M | $53.59M |
Other Short-Term Assets | $109.0K | $320.0K |
YoY Change | -49.07% | -68.84% |
Inventory | $4.913M | $4.695M |
Prepaid Expenses | $1.728M | $2.039M |
Receivables | $290.0K | $123.0K |
Other Receivables | $0.00 | $0.00 |
Total Short-Term Assets | $67.15M | $82.44M |
YoY Change | -50.32% | -46.1% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $7.783M | $7.902M |
YoY Change | 15.87% | 39.0% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $6.235M | $2.438M |
YoY Change | 467.85% | 119.84% |
Total Long-Term Assets | $28.77M | $27.64M |
YoY Change | 10.0% | 10.96% |
TOTAL ASSETS | ||
Total Short-Term Assets | $67.15M | $82.44M |
Total Long-Term Assets | $28.77M | $27.64M |
Total Assets | $95.92M | $110.1M |
YoY Change | -40.54% | -38.11% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $3.520M | $2.209M |
YoY Change | -8.24% | 13.17% |
Accrued Expenses | $9.020M | $9.646M |
YoY Change | -16.42% | 7.24% |
Deferred Revenue | $150.0K | $476.0K |
YoY Change | -90.81% | -74.3% |
Short-Term Debt | $1.641M | $5.384M |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $14.33M | $17.72M |
YoY Change | -11.87% | 38.41% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $44.00K | $112.0K |
YoY Change | -4.35% | -76.91% |
Total Long-Term Liabilities | $44.00K | $112.0K |
YoY Change | -4.35% | -76.91% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $14.33M | $17.72M |
Total Long-Term Liabilities | $44.00K | $112.0K |
Total Liabilities | $30.26M | $34.11M |
YoY Change | -10.28% | 11.46% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$292.8M | -$276.8M |
YoY Change | 44.14% | 56.66% |
Common Stock | $18.00K | $17.00K |
YoY Change | 12.5% | 6.25% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $65.66M | $75.97M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $95.92M | $110.1M |
YoY Change | -40.54% | -38.11% |
Cashflow Statement
Concept | 2023 Q2 | 2023 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$16.03M | -$26.27M |
YoY Change | -39.43% | 5.56% |
Depreciation, Depletion And Amortization | $336.0K | $330.0K |
YoY Change | 31.76% | 58.65% |
Cash From Operating Activities | -$15.25M | -$17.20M |
YoY Change | -10.76% | 7.31% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $209.0K | $599.0K |
YoY Change | -121.22% | -22.61% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $13.87M | $22.08M |
YoY Change | 29.22% | 42.43% |
Cash From Investing Activities | $13.66M | $21.48M |
YoY Change | 40.13% | 45.84% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | -2.670M | -$2.845M |
YoY Change | -769.17% | 66.47% |
NET CHANGE | ||
Cash From Operating Activities | -15.25M | -$17.20M |
Cash From Investing Activities | 13.66M | $21.48M |
Cash From Financing Activities | -2.670M | -$2.845M |
Net Change In Cash | -4.259M | $1.437M |
YoY Change | -38.64% | -147.8% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$15.25M | -$17.20M |
Capital Expenditures | $209.0K | $599.0K |
Free Cash Flow | -$15.46M | -$17.79M |
YoY Change | -4.01% | 5.94% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001818644 | |
CY2023Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2023Q1 | us-gaap |
Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Other Comprehensive Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList
|
http://fasb.org/us-gaap/2022#OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax | |
CY2023Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2023Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2023Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-03-31 | |
CY2023Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023Q1 | dei |
Entity File Number
EntityFileNumber
|
333-259554 | |
CY2023Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
AEye, Inc. | |
CY2023Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2023Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
37-1827430 | |
CY2023Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
One Park Place | |
CY2023Q1 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 200 | |
CY2023Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Dublin | |
CY2023Q1 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | |
CY2023Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
94568 | |
CY2023Q1 | dei |
City Area Code
CityAreaCode
|
(925) | |
CY2023Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
400-4366 | |
CY2023Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2023Q1 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2023Q1 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
176891993 | shares |
CY2023Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
20501000 | usd |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
19064000 | usd |
CY2023Q1 | us-gaap |
Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
53592000 | usd |
CY2022Q4 | us-gaap |
Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
75135000 | usd |
CY2023Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
123000 | usd |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
617000 | usd |
CY2023Q1 | us-gaap |
Inventory Net
InventoryNet
|
4695000 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
4553000 | usd |
CY2023Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
3527000 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
6181000 | usd |
CY2023Q1 | us-gaap |
Assets Current
AssetsCurrent
|
82438000 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
105550000 | usd |
CY2023Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
15152000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
15502000 | usd |
CY2023Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
7902000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
7665000 | usd |
CY2023Q1 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
2150000 | usd |
CY2022Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
2150000 | usd |
CY2023Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
2438000 | usd |
CY2022Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
2473000 | usd |
CY2023Q1 | us-gaap |
Assets
Assets
|
110080000 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
133340000 | usd |
CY2023Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
2209000 | usd |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3218000 | usd |
CY2023Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
9646000 | usd |
CY2023Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
9764000 | usd |
CY2023Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
476000 | usd |
CY2022Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
987000 | usd |
CY2023Q1 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
5384000 | usd |
CY2022Q4 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
8594000 | usd |
CY2023Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
17715000 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
22563000 | usd |
CY2023Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
16287000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
16681000 | usd |
CY2023Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
112000 | usd |
CY2022Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
126000 | usd |
CY2023Q1 | us-gaap |
Liabilities
Liabilities
|
34114000 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
39370000 | usd |
CY2023Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2023Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2023Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | usd |
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | usd |
CY2023Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | shares |
CY2023Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | shares |
CY2023Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
170969581 | shares |
CY2023Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
170969581 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
163099124 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
163099124 | shares |
CY2023Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
17000 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
16000 | usd |
CY2023Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
353533000 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
345742000 | usd |
CY2023Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-810000 | usd |
CY2022Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-1279000 | usd |
CY2023Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-276774000 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-250509000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
75966000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
93970000 | usd |
CY2023Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
110080000 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
133340000 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
636000 | usd |
CY2022Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1082000 | usd |
CY2023Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
2261000 | usd |
CY2022Q1 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
424000 | usd |
CY2023Q1 | lidr |
Interest Expense And Other Nonoperating Expense
InterestExpenseAndOtherNonoperatingExpense
|
-176000 | usd |
CY2022Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
1482000 | usd |
CY2023Q1 | us-gaap |
Gross Profit
GrossProfit
|
-1625000 | usd |
CY2022Q1 | us-gaap |
Gross Profit
GrossProfit
|
-400000 | usd |
CY2023Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
9442000 | usd |
CY2022Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8576000 | usd |
CY2023Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
6268000 | usd |
CY2022Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
4616000 | usd |
CY2023Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8554000 | usd |
CY2022Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
11330000 | usd |
CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
24264000 | usd |
CY2022Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
24522000 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-25889000 | usd |
CY2022Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-24922000 | usd |
CY2023Q1 | lidr |
Gain Loss On Fair Value Of Convertible Note And Warrant Liabilities
GainLossOnFairValueOfConvertibleNoteAndWarrantLiabilities
|
-810000 | usd |
CY2022Q1 | lidr |
Gain Loss On Fair Value Of Convertible Note And Warrant Liabilities
GainLossOnFairValueOfConvertibleNoteAndWarrantLiabilities
|
-32000 | usd |
CY2023Q1 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
277000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24881000 | usd |
CY2022Q1 | lidr |
Interest Expense And Other Nonoperating Expense
InterestExpenseAndOtherNonoperatingExpense
|
343000 | usd |
CY2023Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-357000 | usd |
CY2022Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
49000 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
19000 | usd |
CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
8000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-26265000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24881000 | usd |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.16 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.16 | |
CY2022Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.16 | |
CY2022Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.16 | |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
165865864 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
165865864 | shares |
CY2022Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
155515093 | shares |
CY2022Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
155515093 | shares |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-26265000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
490000 | usd |
CY2022Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
-1056000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period After Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
|
-21000 | usd |
CY2022Q1 | us-gaap |
Other Comprehensive Income Loss Financial Liability Fair Value Option Unrealized Gain Loss Arising During Period After Tax
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax
|
0 | usd |
CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-25796000 | usd |
CY2022Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-25937000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
93970000 | usd |
CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
6513000 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
391000 | usd |
CY2023Q1 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
867000 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
1755000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
469000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-26265000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
75966000 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
168767000 | usd |
CY2022Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
5340000 | usd |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
222000 | usd |
CY2022Q1 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
1149000 | usd |
CY2022Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
-1056000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24881000 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
147243000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-26265000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24881000 | usd |
CY2023Q1 | us-gaap |
Depreciation
Depreciation
|
330000 | usd |
CY2022Q1 | us-gaap |
Depreciation
Depreciation
|
208000 | usd |
CY2023Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
53000 | usd |
CY2022Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
0 | usd |
CY2023Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
350000 | usd |
CY2022Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
317000 | usd |
CY2023Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
208000 | usd |
CY2022Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
267000 | usd |
CY2023Q1 | lidr |
Gain Loss On Fair Value Of Convertible Note And Warrant Liabilities
GainLossOnFairValueOfConvertibleNoteAndWarrantLiabilities
|
-810000 | usd |
CY2022Q1 | lidr |
Gain Loss On Fair Value Of Convertible Note And Warrant Liabilities
GainLossOnFairValueOfConvertibleNoteAndWarrantLiabilities
|
-32000 | usd |
CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
6513000 | usd |
CY2022Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
5340000 | usd |
CY2023Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-33000 | usd |
CY2022Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-594000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-494000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-3930000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
386000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
436000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-2722000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-510000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-71000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-400000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-985000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-567000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-134000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-645000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-392000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-325000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-511000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-767000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-17195000 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-16023000 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
599000 | usd |
CY2022Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
774000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
76000 | usd |
CY2022Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
0 | usd |
CY2023Q1 | us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
22000000 | usd |
CY2022Q1 | us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
15500000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
21477000 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
14726000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
323000 | usd |
CY2022Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
222000 | usd |
CY2023Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
868000 | usd |
CY2022Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
1931000 | usd |
CY2023Q1 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
2300000 | usd |
CY2022Q1 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
0 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-2845000 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-1709000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
1437000 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-3006000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
21214000 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
16333000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
22651000 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
13327000 | usd |
CY2023Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | usd |
CY2022Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | usd |
CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
85000 | usd |
CY2022Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd |
CY2023Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
19000 | usd |
CY2022Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
260000 | usd |
CY2023Q1 | lidr |
Proceeds From Exercise Of Stock Options Included In Prepaid And Other Current Assets
ProceedsFromExerciseOfStockOptionsIncludedInPrepaidAndOtherCurrentAssets
|
68000 | usd |
CY2022Q1 | lidr |
Proceeds From Exercise Of Stock Options Included In Prepaid And Other Current Assets
ProceedsFromExerciseOfStockOptionsIncludedInPrepaidAndOtherCurrentAssets
|
0 | usd |
CY2023Q1 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
1755000 | usd |
CY2022Q1 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
0 | usd |
CY2023Q1 | lidr |
Tax Withholding Accrued Share Based Payment Arrangement
TaxWithholdingAccruedShareBasedPaymentArrangement
|
3000 | usd |
CY2022Q1 | lidr |
Tax Withholding Accrued Share Based Payment Arrangement
TaxWithholdingAccruedShareBasedPaymentArrangement
|
53000 | usd |
CY2023Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="margin-bottom:0.12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which potentially subject the Company to concentration of credit risk consist primarily of cash, cash equivalents, and marketable securities, and accounts receivable. The Company places its cash and cash equivalents with major financial institutions, which management assesses to be of high credit quality, to limit the exposure of each investment. The Company’s marketable securities have investment grade ratings when purchased which mitigates risk.</span></div><div style="margin-bottom:0.12pt;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s accounts receivables are derived from customers located in the U.S., Europe, and Asia. The Company mitigates its credit risks by performing ongoing credit evaluations of its customers’ financial conditions. The Company generally does not require collateral.</span></div> | |
CY2023Q1 | lidr |
Class Of Warrant Or Right Term Of Contract
ClassOfWarrantOrRightTermOfContract
|
P4Y | |
CY2022Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
8713000 | usd |
CY2023Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
|
4055000 | usd |
CY2023Q1 | lidr |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Income Expense
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherIncomeExpense
|
-808000 | usd |
CY2023Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
|
-21000 | usd |
CY2023Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
5487000 | usd |
CY2023Q1 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
1842000 | usd |
CY2022Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
2022000 | usd |
CY2023Q1 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
2804000 | usd |
CY2022Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
2484000 | usd |
CY2023Q1 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
49000 | usd |
CY2022Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
47000 | usd |
CY2023Q1 | us-gaap |
Inventory Net
InventoryNet
|
4695000 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
4553000 | usd |
CY2023Q1 | us-gaap |
Inventory Noncurrent
InventoryNoncurrent
|
1527000 | usd |
CY2022Q4 | us-gaap |
Inventory Noncurrent
InventoryNoncurrent
|
1491000 | usd |
CY2023Q1 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
273000 | usd |
CY2022Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
833000 | usd |
CY2023Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
2039000 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
4203000 | usd |
CY2023Q1 | us-gaap |
Advances On Inventory Purchases
AdvancesOnInventoryPurchases
|
986000 | usd |
CY2022Q4 | us-gaap |
Advances On Inventory Purchases
AdvancesOnInventoryPurchases
|
984000 | usd |
CY2023Q1 | lidr |
Demonstration Units Current
DemonstrationUnitsCurrent
|
182000 | usd |
CY2022Q4 | lidr |
Demonstration Units Current
DemonstrationUnitsCurrent
|
281000 | usd |
CY2023Q1 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
320000 | usd |
CY2022Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
713000 | usd |
CY2023Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
3527000 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
6181000 | usd |
CY2023Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
602000 | usd |
CY2022Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
577000 | usd |
CY2023Q1 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
79000 | usd |
CY2022Q1 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
63000 | usd |
CY2023Q1 | us-gaap |
Lease Cost
LeaseCost
|
681000 | usd |
CY2022Q1 | us-gaap |
Lease Cost
LeaseCost
|
640000 | usd |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
1889000 | usd |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
2570000 | usd |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
2583000 | usd |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
2660000 | usd |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
2701000 | usd |
CY2023Q1 | lidr |
Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
|
11116000 | usd |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
23519000 | usd |
CY2023Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
4775000 | usd |
CY2023Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
18744000 | usd |
CY2023Q1 | us-gaap |
Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
|
188000 | usd |
CY2022Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1082000 | usd |
CY2022Q1 | us-gaap |
Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
|
-336000 | usd |
CY2023Q1 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
12000 | usd |
CY2022Q1 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
7000 | usd |
CY2023Q1 | lidr |
Interest Expense And Other Nonoperating Expense
InterestExpenseAndOtherNonoperatingExpense
|
-176000 | usd |
CY2022Q1 | lidr |
Interest Expense And Other Nonoperating Expense
InterestExpenseAndOtherNonoperatingExpense
|
343000 | usd |
CY2023Q1 | us-gaap |
Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
|
469000 | usd |
CY2022Q1 | us-gaap |
Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
|
-1056000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-26265000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24881000 | usd |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
165865864 | shares |
CY2022Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
155515093 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
165865864 | shares |
CY2022Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
155515093 | shares |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.16 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.16 | |
CY2022Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.16 | |
CY2022Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.16 | |
CY2023Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
67911894 | shares |
CY2022Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
50024185 | shares |
CY2023Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
6513000 | usd |
CY2022Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
5340000 | usd |
CY2023Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P1Y18D | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
|
1.045 | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.048 | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
636000 | usd |
CY2022Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1082000 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
636000 | usd |
CY2023Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
476000 | usd |
CY2023Q1 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
476000 | usd |
CY2022Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
987000 | usd |
CY2021Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
2918000 | usd |
CY2023Q1 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
511000 | usd |
CY2022Q1 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
767000 | usd |
CY2023Q1 | lidr |
Contract With Customer Liability Increase For Invoice Issued On Performance Obligations Not Yet Satisfied
ContractWithCustomerLiabilityIncreaseForInvoiceIssuedOnPerformanceObligationsNotYetSatisfied
|
0 | usd |
CY2022Q1 | lidr |
Contract With Customer Liability Increase For Invoice Issued On Performance Obligations Not Yet Satisfied
ContractWithCustomerLiabilityIncreaseForInvoiceIssuedOnPerformanceObligationsNotYetSatisfied
|
0 | usd |
CY2023Q1 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
476000 | usd |
CY2022Q1 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
2151000 | usd |
CY2023Q1 | us-gaap |
Restructuring Charges
RestructuringCharges
|
1253000 | usd |
CY2022 | us-gaap |
Restructuring Charges
RestructuringCharges
|
0 | usd |
CY2023Q1 | us-gaap |
Restructuring Charges
RestructuringCharges
|
1253000 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
19000 | usd |
CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
8000 | usd |